PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?

Authors : Pondé N, Gelber Rd, Piccart-Gebhart M
Year : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pages : 1